Pascal Laforêt

1.0k total citations
18 papers, 367 citations indexed

About

Pascal Laforêt is a scholar working on Molecular Biology, Physiology and Genetics. According to data from OpenAlex, Pascal Laforêt has authored 18 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Physiology and 6 papers in Genetics. Recurrent topics in Pascal Laforêt's work include Lysosomal Storage Disorders Research (7 papers), Glycogen Storage Diseases and Myoclonus (6 papers) and Neurogenetic and Muscular Disorders Research (6 papers). Pascal Laforêt is often cited by papers focused on Lysosomal Storage Disorders Research (7 papers), Glycogen Storage Diseases and Myoclonus (6 papers) and Neurogenetic and Muscular Disorders Research (6 papers). Pascal Laforêt collaborates with scholars based in France, United States and United Kingdom. Pascal Laforêt's co-authors include Kristl G. Claeys, B. Eymard, B. Eymard, Catherine Caillaud, Frédéric Lofaso, N. Pellegrini, Mariangela Pellegrini, Norma B. Romero, Giuseppe Ronzitti and Federico Mingozzi and has published in prestigious journals such as PLoS ONE, Neurology and American Journal Of Pathology.

In The Last Decade

Pascal Laforêt

18 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal Laforêt France 9 178 133 118 85 50 18 367
Claudio Semplicini Italy 17 238 1.3× 214 1.6× 185 1.6× 51 0.6× 55 1.1× 25 480
Ziad Rifai United States 8 232 1.3× 79 0.6× 97 0.8× 62 0.7× 42 0.8× 9 361
Robert‐Yves Carlier France 12 253 1.4× 135 1.0× 155 1.3× 93 1.1× 132 2.6× 37 546
Carlos Cervera Spain 13 291 1.6× 61 0.5× 156 1.3× 143 1.7× 39 0.8× 20 465
K. Eger Germany 9 156 0.9× 226 1.7× 206 1.7× 69 0.8× 46 0.9× 19 464
C. Iturriaga Spain 8 188 1.1× 195 1.5× 49 0.4× 43 0.5× 139 2.8× 8 464
Anne-Marie Childs United Kingdom 6 232 1.3× 32 0.2× 57 0.5× 51 0.6× 37 0.7× 6 400
Astrid Brull Spain 13 216 1.2× 71 0.5× 198 1.7× 17 0.2× 26 0.5× 22 398
Liliana Vercelli Italy 9 167 0.9× 47 0.4× 43 0.4× 79 0.9× 46 0.9× 17 276
Jorge Alonso‐Pérez Spain 10 100 0.6× 82 0.6× 63 0.5× 35 0.4× 24 0.5× 26 250

Countries citing papers authored by Pascal Laforêt

Since Specialization
Citations

This map shows the geographic impact of Pascal Laforêt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Laforêt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Laforêt more than expected).

Fields of papers citing papers by Pascal Laforêt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Laforêt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Laforêt. The network helps show where Pascal Laforêt may publish in the future.

Co-authorship network of co-authors of Pascal Laforêt

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Laforêt. A scholar is included among the top collaborators of Pascal Laforêt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Laforêt. Pascal Laforêt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kushlaf, Hani, Jordi Díaz‐Manera, Drago Bratkovic, et al.. (2025). Switching Enzyme Replacement Therapy for Late‐Onset Pompe Disease From Alglucosidase Alfa to Cipaglucosidase Alfa Plus Miglustat: Post Hoc Effect Size Analysis of PROPEL. Muscle & Nerve. 72(2). 230–239. 1 indexed citations
2.
Imbard, Apolline, Hortense de Calbiac, Pascal Laforêt, et al.. (2024). Circulatory response to exercise relative to oxygen uptake assessed in the follow‐up of patients with fatty acid beta‐oxidation disorders. Journal of Inherited Metabolic Disease. 48(1). e12819–e12819. 2 indexed citations
3.
Voisin, M., et al.. (2023). Identification of wheelchair seating criteria in adults with neuromuscular diseases: A Delphi study. PLoS ONE. 18(9). e0290627–e0290627. 2 indexed citations
4.
Orlikowski, David, Bernard Clair, Hélène Prigent, et al.. (2022). Nusinersen treatment in adults with severe spinal muscular atrophy: A real-life retrospective observational cohort study. Revue Neurologique. 178(3). 234–240. 7 indexed citations
5.
Querin, Giorgia, Timothée Lenglet, Rabab Debs, et al.. (2021). Development of new outcome measures for adult SMA type III and IV: a multimodal longitudinal study. Journal of Neurology. 268(5). 1792–1802. 21 indexed citations
6.
Ronzitti, Giuseppe, Fanny Collaud, Pascal Laforêt, & Federico Mingozzi. (2019). Progress and challenges of gene therapy for Pompe disease. Annals of Translational Medicine. 7(13). 287–287. 35 indexed citations
7.
Laforêt, Pascal, Dalila Habès, Philippe Labrune, et al.. (2019). Whole‐Body Muscle Magnetic Resonance Imaging in Glycogen‐Storage Disease Type III. Muscle & Nerve. 60(1). 72–79. 6 indexed citations
8.
Vidal, Pierre, Giuseppe Ronzitti, Fanny Collaud, et al.. (2017). Adeno associated vector-based gene therapy strategy for type 3 glycogen storage disease. Neuromuscular Disorders. 27. S246–S246. 1 indexed citations
9.
Mendili, Mohamed‐Mounir El, Timothée Lenglet, Tanya Stojkovic, et al.. (2016). Cervical Spinal Cord Atrophy Profile in Adult SMN1-Linked SMA. PLoS ONE. 11(4). e0152439–e0152439. 23 indexed citations
10.
Hatem, Stéphane, M.H. Becquemin, Roseli Saraiva Moreira Bittar, et al.. (2015). Exploration of muscle metabolism during exercise and muscle imaging in late-onset form of multiple acyl-coA dehydrogenase deficiency (MADD). Neuromuscular Disorders. 25. S203–S203. 1 indexed citations
11.
Billot, S., Dominique Hervé, Hasan O. Akman, et al.. (2012). Acute but transient neurological deterioration revealing adult polyglucosan body disease. Journal of the Neurological Sciences. 324(1-2). 179–182. 12 indexed citations
12.
Béhin, Anthony, Claude Jardel, Kristl G. Claeys, et al.. (2012). Adult cases of mitochondrial DNA depletion due to TK2 defect. Neurology. 78(9). 644–648. 35 indexed citations
13.
Claeys, Kristl G., Jean‐Jacques Martin, Emmanuelle Lacène, et al.. (2010). DNAJB2 Expression in Normal and Diseased Human and Mouse Skeletal Muscle. American Journal Of Pathology. 176(6). 2901–2910. 18 indexed citations
14.
Wary, Claire, Aleksandra Nadaj‐Pakleza, Pascal Laforêt, et al.. (2010). Investigating glycogenosis type III patients with multi-parametric functional NMR imaging and spectroscopy. Neuromuscular Disorders. 20(8). 548–558. 31 indexed citations
15.
Claeys, Kristl G., Nicole Monnier, Pascal Laforêt, et al.. (2009). G.P.1.02 Phenotypic spectrum of core-rod myopathy caused by dominant or recessive RYR1 mutations. Neuromuscular Disorders. 19(8-9). 556–556. 2 indexed citations
16.
Bevilacqua, Jorge A., Marc Bitoun, Valérie Biancalana, et al.. (2008). “Necklace” fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy. Acta Neuropathologica. 117(3). 283–291. 85 indexed citations
17.
Escolar, Diana M., et al.. (2006). G.P.1 01 Clinical presentation and disease progression in late-onset Pompe disease. Neuromuscular Disorders. 16(9-10). 654–654. 1 indexed citations
18.
Pellegrini, N., Pascal Laforêt, Mariangela Pellegrini, et al.. (2005). Respiratory insufficiency and limb muscle weakness in adults with Pompe’s disease. European Respiratory Journal. 26(6). 1024–1031. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudio Semplicini Breakdown of academic impact, for papers by Ziad Rifai Breakdown of academic impact, for papers by Robert‐Yves Carlier Breakdown of academic impact, for papers by Carlos Cervera Breakdown of academic impact, for papers by K. Eger Breakdown of academic impact, for papers by C. Iturriaga Breakdown of academic impact, for papers by Anne-Marie Childs Breakdown of academic impact, for papers by Astrid Brull Breakdown of academic impact, for papers by Liliana Vercelli Breakdown of academic impact, for papers by Jorge Alonso‐Pérez
Rankless by CCL
2026